Trials / Completed
CompletedNCT04061265
Articaine Efficacy and Safety for Children Below Age of 4-years
Articaine Efficacy and Safety in Young Children Below Age of Four Years: An Equivalent Parallel Randomized Control Trial
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 37 Months – 47 Months
- Healthy volunteers
- Not accepted
Summary
Pain control is one of the significant behavior determinants in the dental office and shaping the future attitude toward dentistry, especially in children. One of widely used local anesthetic agents is articaine hydrochloride because of its superior potency, over traditionally used 2% lidocaine. Therefore, this study intends to get the benefits of articaine efficiency and apply it in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml | Local anesthetic agent |
| DRUG | lidocaine hydrochloride 2% and epinephrine 1:100000 | Local anesthetic agent |
Timeline
- Start date
- 2019-08-25
- Primary completion
- 2020-01-15
- Completion
- 2020-01-15
- First posted
- 2019-08-19
- Last updated
- 2020-02-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04061265. Inclusion in this directory is not an endorsement.